Getting started
Section 1 of 21Learning Objectives
Learning Objectives
Section: Learning Objectives
Explain how this ancillary method supports, not replaces, morphologic and clinical correlation in hematologic malignancy workup.
- Distinguish karyotype, FISH, and PCR-based molecular assays
- List representative abnormalities: BCR-ABL1, t(15;17), NPM1, FLT3 among examples
- Explain MLS role in specimen routing and report awareness
- Avoid treating single mutations as definitive diagnosis without integrated report
